SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-003928
Filing Date
2020-01-14
Accepted
2020-01-14 16:17:14
Documents
34
Period of Report
2019-11-30

Document Format Files

Seq Description Document Type Size
1 10-Q a20-1548_110q.htm 10-Q 388458
2 EX-31.1 a20-1548_1ex31d1.htm EX-31.1 10821
3 EX-31.2 a20-1548_1ex31d2.htm EX-31.2 10794
4 EX-32.1 a20-1548_1ex32d1.htm EX-32.1 6286
5 EX-32.2 a20-1548_1ex32d2.htm EX-32.2 6261
  Complete submission text file 0001104659-20-003928.txt   1458385

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20191130.xml EX-101.INS 211442
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20191130.xsd EX-101.SCH 16320
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20191130_cal.xml EX-101.CAL 17933
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20191130_lab.xml EX-101.LAB 145136
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20191130_pre.xml EX-101.PRE 88779
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20191130_def.xml EX-101.DEF 32851
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-23425 | Film No.: 20526221
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences